Arkis BioSciences

Biotechnology ResearchTennessee, United States11-50 Employees

Arkis BioSciences develops advanced treatments for intracranial hypertension, including hydrocephalus and other related disorders, ranging from surgical tools to state of the art implantables.  Founded in 2013 by a neurosurgeon, former engineering patent examiner, and business developer, Arkis began development of a portfolio of products that results in safer and less invasive surgeries as well as improved shunt options to result in personalized treatments for a leap in patient outcomes.

Sign up for free to view info

Email Format Employee directory